9960 — Kindstar Globalgene Technology Share Price
0.000.00%
Last trade - 00:00- HK$1.40bn
- HK$160.12m
- CNY927.57m
- 20
- 41
- 82
- 46
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.45 | ||
| Price to Tang. Book | 0.46 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.36 | ||
| EV to EBITDA | 3.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.54% | ||
| Return on Equity | -1.93% | ||
| Operating Margin | -4.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 891.39 | 930.67 | 1,386.59 | 967.26 | 927.57 | 1,642.99 | n/a | 2.18% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -82.73 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kindstar Globalgene Technology Inc is an investment holding company engaged in the provision of clinical testing services. The Company operates nine segments. The Hematology Testing segment includes testing services related to blood diseases. The Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. The Infectious Diseases segment includes testing services from the infection department. The Oncology segment includes testing related to oncology diseases. The Neurology segment includes testing services related to neurological diseases. The Maternity-Related Diseases segment includes testing services related to maternity. The Coronavirus Disease 2019 (COVID-19) Related Testing segment includes testing services related to COVID-19. The Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Company also operates Contract Research Organization (CROs) and Research and Development (R&D) Project segment and Others segment.
Directors
- Shiang Huang CHM (62)
- Haijie Chai CFO (42)
- Zanbing Tu COO (49)
- Wai Ling Chan SEC
- Lu Huang NED (47)
- Zuie-Chin Huang NED (55)
- Wei Peng NED (34)
- Huaming Gu NID (57)
- Xinping Xia NID (56)
- Shanglong Yao NID (65)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 24th, 2007
- Public Since
- July 16th, 2021
- No. of Employees
- 3,011
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 1,033,659,296
- Address
- East Lake High Tech Zone, WUHAN
- Web
- https://www.kindstar.com.cn/
- Phone
- Auditors
- Ernst & Young Australia
Upcoming Events for 9960
Kindstar Globalgene Technology Inc Annual Shareholders Meeting
Dividend For 9960.HK - 0.0238 HKD
Half Year 2025 Kindstar Globalgene Technology Inc Earnings Release
Similar to 9960
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
What is the Kindstar Globalgene Technology share price?
As of Today at 21:34 UTC, shares in Kindstar Globalgene Technology are trading at HK$1.30. This share price information is delayed by 15 minutes.
How has the Kindstar Globalgene Technology share price performed this year?
Shares in Kindstar Globalgene Technology last closed at HK$1.30 and the price had moved by -16.67% over the past 365 days. In terms of relative price strength the Kindstar Globalgene Technology share price has underperformed the FTSE Developed Asia Pacific Index by -15.71% over the past year.
What are the analyst and broker recommendations for Kindstar Globalgene Technology?
The overall consensus recommendation for Kindstar Globalgene Technology is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Kindstar Globalgene Technology dividend yield?
The Kindstar Globalgene Technology dividend yield is 1.83% based on the trailing twelve month period.
Does Kindstar Globalgene Technology pay a dividend?
Last year, Kindstar Globalgene Technology paid a total dividend of CNY0.02, and it currently has a trailing dividend yield of 1.83%.Looking ahead, shares in Kindstar Globalgene Technology are due to go ex-dividend on 2025-06-09 and the next dividend pay date is 2025-08-27.
When does Kindstar Globalgene Technology next pay dividends?
Kindstar Globalgene Technology are due to go ex-dividend on 2025-06-09 and the next dividend pay date is 2025-08-27. The historic dividend yield on Kindstar Globalgene Technology shares is currently 1.83%.
How do I buy Kindstar Globalgene Technology shares?
To buy shares in Kindstar Globalgene Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kindstar Globalgene Technology?
As of the previous close price of HK$1.30, shares in Kindstar Globalgene Technology had a market capitalisation of HK$1.40bn.
Where are Kindstar Globalgene Technology shares listed?
Here are the trading details for Kindstar Globalgene Technology:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9960
What kind of share is Kindstar Globalgene Technology?
Based on an overall assessment of its quality, value and momentum Kindstar Globalgene Technology is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kindstar Globalgene Technology share price forecast for 2025?
The analyst consensus target price for shares in Kindstar Globalgene Technology is HK$3.23. That is 148.51% above the last closing price of HK$1.30.
Analysts covering Kindstar Globalgene Technology currently have a consensus Earnings Per Share (EPS) forecast of CNY0.13 for the next financial year.
Find out moreWhat is the trend in the Kindstar Globalgene Technology share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kindstar Globalgene Technology. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +8.47%.
As of the last closing price of HK$1.30, shares in Kindstar Globalgene Technology were trading +5.27% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kindstar Globalgene Technology PE Ratio?
The Kindstar Globalgene Technology PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kindstar Globalgene Technology?
Kindstar Globalgene Technology's management team is headed by:
- Shiang Huang - CHM
- Haijie Chai - CFO
- Zanbing Tu - COO
- Wai Ling Chan - SEC
- Lu Huang - NED
- Zuie-Chin Huang - NED
- Wei Peng - NED
- Huaming Gu - NID
- Xinping Xia - NID
- Shanglong Yao - NID